Cyprus vs Guyana: Cause of death, by non-communicable diseases, ages 5-14, male
Cyprus
44.7%
in 2021
Guyana
43.3%
in 2021
Cyprus rank
61st
Guyana rank
64th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Cyprus
- Guyana
How they compare
Cyprus currently reports 44.7% against 43.3% in Guyana, a difference of 1.4%.
Across all 6 years both countries report, Cyprus has been ahead every year.
Cyprus ranks 61st and Guyana ranks 64th of 185 countries.
Cyprus has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cyprus | Guyana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 59.3% | 33.4% | 25.9% | Cyprus |
| 2010s | 79.6% | 38.9% | 40.7% | Cyprus |
| 2020s | 64.9% | 45.0% | 19.9% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Cyprus or Guyana?
- Cyprus, at 44.7% against 43.3% in Guyana as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Cyprus and Guyana?
- 1.4%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Guyana?
- 6 years are reported by both, from 2000 to 2021.
- How do Cyprus and Guyana rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Cyprus ranks 61st and Guyana ranks 64th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.